SCHEMBL6599300

SCHEMBL6599300

CN1CCN(C(=O)c2c[nH]cc2-c2cc(Br)cc3ccccc23)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ GLA P06280 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ HPGD P15428 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HRH4 Q9H3N8 8/20 0.46
▸ LMNA P02545 2/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.46
▸ TSHR P16473 2/20 0.45
▸ HTR2C P28335 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600644 0.86 LMNA (0.51) KDM4EALDH1A1GLAGAACASP1
SCHEMBL6599453 0.84 KDM4E (0.56) KDM4EALDH1A1GLAGAACASP1
SCHEMBL6598615 0.79 MEN1 (0.49) KDM4EALDH1A1GLAHSD17B10HPGD
SCHEMBL6927839 0.72 MAPK14 (0.47) KDM4EALDH1A1L3MBTL1LMNAHTR2C
SCHEMBL3518475 0.71 ALDH1A1 (0.67) KDM4EALDH1A1GLAGAACASP1
SCHEMBL6599155 0.71 ALDH1A1 (0.57) KDM4EALDH1A1HSD17B10HPGDLMNA
SCHEMBL6922520 0.71 MAPK14 (0.47) KDM4EALDH1A1L3MBTL1LMNAHTR2C
SCHEMBL10722273 0.69 L3MBTL1 (0.74) KDM4EALDH1A1HPGDL3MBTL1LMNA
SCHEMBL27460024 0.68 KDM4E (0.55) KDM4EALDH1A1GLAGAACASP1
SCHEMBL29434773 0.68 CYP2A6 (0.48) KDM4EALDH1A1GLAGAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 — — EP disclosed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 — — US disclosed
EP-1169320-A4 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2002-10-30 — — EP disclosed
EP-1169320-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG Chem Investment, Ltd. (KR) 2002-01-09 — — EP disclosed
WO-2000064891-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD. (KR) 2000-11-02 — — WO disclosed
Send feedback